首页> 外文期刊>Journal of drug targeting >Topological properties of the drug targets regulated by microRNA in human protein-protein interaction network.
【24h】

Topological properties of the drug targets regulated by microRNA in human protein-protein interaction network.

机译:在人类蛋白质-蛋白质相互作用网络中受microRNA调控的药物靶标的拓扑特性。

获取原文
获取原文并翻译 | 示例
           

摘要

The investigation of topological properties of proteins in protein-protein interaction network (PPIN) has great potentials to identify basic protein functions and mechanisms of action. Based on human PPIN, previous study has shown that the topological properties of drug targets are significantly distinguished from those of proteins that are not targeted by drugs (non-drug-targets). MicroRNAs (miRNAs) are known to regulate gene expression at the post-transcriptional level. To determine whether the differences in topological properties between drug targets and non-drug-targets are dominated by the proteins that are regulated by miRNA, we divided the drug targets into two sets: those are regulated by miRNA (mir-drug-targets) and those are not regulated by miRNA (non-mir-drug-targets). We compared the probability of interactions and five topological properties among the three types of proteins in human PPIN. Our results demonstrated that mir-drug-targets preferentially interact with other mir-drug-targets and tend to be hub-bottlenecks. However, there was no bias on topological properties between non-mir-drug-targets and non-drug-targets. The same topological features are observed among non-drug targets. These findings indicate that miRNA regulation has an important role in human PPIN, and may be useful in the development of novel drugs.
机译:蛋白质-蛋白质相互作用网络(PPIN)中蛋白质拓扑特性的研究具有识别基本蛋白质功能和作用机制的巨大潜力。基于人的PPIN,先前的研究表明,药物靶标的拓扑特性与没有被药物靶向的蛋白(非药物靶标)的拓扑特性明显不同。已知MicroRNA(miRNA)在转录后水平上调控基因表达。为了确定药物靶标和非药物靶标之间的拓扑特性差异是否受miRNA调控的蛋白质支配,我们将药物靶标分为两组:受miRNA调控的靶标(mir-drug-targets)和那些不受miRNA(非mir-drug-targets)的调节。我们比较了人类PPIN中三种蛋白质之间相互作用的可能性和五种拓扑性质。我们的研究结果表明,mir药物靶标优先与其他mir药物靶标相互作用,并且往往是枢纽瓶颈。但是,在非mir-药物靶标和非药物-靶标之间的拓扑性质上没有偏见。在非药物靶标中观察到相同的拓扑特征。这些发现表明,miRNA调控在人类PPIN中具有重要作用,并且可能在新药开发中有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号